Skip to main content
OpenTrials

Clinical trial condition

Clear-cell metastatic renal cell carcinoma

Explore clinical trials studying Clear-cell metastatic renal cell carcinoma. Study availability and eligibility vary by location and protocol.

52 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Clear-cell metastatic renal cell carcinoma trial results

Completed

Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma

NCT01510119

Conditions
Clear-cell metastatic renal cell carcinoma, Metastatic Clear Cell Renal Cell Carcinoma
Locations
  • University of Medicine and Dentistry of New Jersey New Brunswick, New Jersey, United States
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University of Pittsburgh, Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule

NCT01499121

Conditions
Clear Cell, Metastatic Renal Cell Carcinoma, Clear-cell metastatic renal cell carcinoma
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BC Cancer Agency - Vancouver Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View all 13 locations
View Trial Details
Completed

First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma

NCT01521715

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations
  • Urolog. Klinik im Waldkrankenhaus St. Marien, Friedrich-Alexander-Universität Erlangen, Germany
  • Universitätsklinikum Essen, Klinik f. Urologie Essen, Germany
  • Med. Klinik II, Johann-Wolfgang-Goethe-Universität Frankfurt, Germany
  • Medizinisches Versorgungszentrum (MVZ) Osthessen GmbH Fulda, Germany
View Trial Details
Completed

Biomarkers Before and After Nephrectomy of Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus

NCT01715935

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations
  • CHRU Besançon Besançon, France
  • Hôpital Henri Mondor Créteil, France
  • Centre Hospitalier Départemental Vendée La Roche-sur-Yon, France
  • Hôpital Saint Eloi - CHU Montpellier Montpellier, France
View Trial Details
Active, Not Recruiting

Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

NCT04696731

Conditions
Adenocarcinoma, Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Carcinoma, +15 more
Locations
  • City of Hope Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • UCSF Medical Center San Francisco, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
View Trial Details

Related conditions